ABSTRACT OBJECTIVES This study tested whether combined invasive hemodynamic and echocardiographic ramp tests can help optimize patient management.
The intent of this study is to develop an evidencebased approach to the management of cfLVAD patients based on the interaction between device function and patient hemodynamics. We applied a standardized hemodynamic ramp protocol in clinically stable cfLVAD patients to assess the impact of acute changes in cfLVAD speed on hemodynamics and LV unloading. We hypothesize that the findings of this study will have important implications for the refinement of management guidelines and establish the role of periodic hemodynamic monitoring in cfLVAD patients.
METHODS
In this prospective study, 35 consecutive cfLVAD pa- Accordingly, comparisons will be based on ramp step numbers and Fick CO, not device-estimated flows.
RAMP STUDY RESULTS. The slopes of the relationships between RPM steps and each of the hemodynamic and echocardiographic parameters are summarized in Table 2 . At RPM step 0 ( Figure 3C ) the points shifted upward and rightward, with more patients moving into the left heart failure and volume overload zones. In contrast, at RPM step 9, the points shifted downward and leftward, with some shifting to the right heart failure and hypovolemic zones. These data show that the PCWP-CVP working point can be manipulated by changing RPM, but that it cannot always be positioned for both parameters within the normal limits. shown in Figure 4E . Uriel et al.
JACC: HEART FAILURE VOL. 4, NO. 3, 2016
Hemodynamic
have reported in our prior studies (8, 12) . Even at these speeds, some of the patients remaining outside the normal hemodynamic boundaries had balanced CVP and PCWP elevations (volume overload state, w12%), some had mainly isolated CVP elevation (right heart failure, w9%) and some had low CVPs and PCWPs (hypovolemia, w9%) suggesting the need for adjustment of medical management.
Our data, when displayed on the CVP-PCWP diagram with color coding for CI (as in Figure 4 Figure 4C suggests that an important contributing factor is hypovolemia. Similarly, the patient illustrated in Figure 4D suggests that right heart failure should be investigated. The average slope values summarized in Table 2 STUDY LIMITATIONS. This is a single-center study with a small sample size. Because medical management practices vary significantly between sites, it is uncertain whether the same hemodynamic variability would be encountered at all centers. It is noteworthy, however, that in most LVAD studies, >20% of mortality and morbidity is attributed to worsening heart failure (including right heart failure) (2, 18) . This might be an unrecognized clue that fluid overload may be present in more patients than previously appreciated.
Perhaps most importantly, this study only 
